Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiddo J Lambers Heerspink

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Advances in Chronic Kidney Disease|July 26, 2011
Therapeutic approaches in lowering albuminuria: travels along the renin-angiotensin-aldosterone-system pathwayHiddo J Lambers Heerspink
Journal of the American College of Cardiology|November 26, 2013
Are renin-angiotensin-aldosterone system inhibitors lifesaving in chronic kidney disease?Kevin Damman, Hiddo J Lambers-Heerspink
American Journal of Nephrology|April 24, 2010
Debate: PRO position. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?Hiddo J Lambers Heerspink, Dick de Zeeuw
Journal of the American Society of Nephrology : JASN|June 14, 2014
Are post-trial observational studies useful?Hiddo J Lambers Heerspink, Dick de Zeeuw
Nature Reviews. Endocrinology|March 27, 2013
Dual RAAS blockade has dual effects on outcomeHiddo J Lambers Heerspink, Dick de Zeeuw
Circulation|March 2, 2011
ONTARGET still OFF-TARGET?Hiddo J Lambers Heerspink, Dick de Zeeuw
The Review of Diabetic Studies : RDS|January 21, 2012
The kidney in type 2 diabetes therapyHiddo J Lambers Heerspink, Dick de Zeeuw
Nature Reviews. Nephrology|January 21, 2015
Clinical trials: New nonabsorbable potassium-exchange resins in hyperkalaemiaSara S Roscioni, Hiddo J Lambers Heerspink
Clinical Journal of the American Society of Nephrology : CJASN|April 19, 2015
Rebuttal of the Con View: Albuminuria Is an Appropriate Therapeutic Target in Patients with CKDHiddo J Lambers Heerspink, Ron T Gansevoort
Clinical Journal of the American Society of Nephrology : CJASN|April 19, 2015
Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro ViewHiddo J Lambers Heerspink, Ron T Gansevoort
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Advances in Chronic Kidney Disease|July 26, 2011
Therapeutic approaches in lowering albuminuria: travels along the renin-angiotensin-aldosterone-system pathwayHiddo J Lambers Heerspink
Journal of the American College of Cardiology|November 26, 2013
Are renin-angiotensin-aldosterone system inhibitors lifesaving in chronic kidney disease?Kevin Damman, Hiddo J Lambers-Heerspink
American Journal of Nephrology|April 24, 2010
Debate: PRO position. Should microalbuminuria ever be considered as a renal endpoint in any clinical trial?Hiddo J Lambers Heerspink, Dick de Zeeuw
Journal of the American Society of Nephrology : JASN|June 14, 2014
Are post-trial observational studies useful?Hiddo J Lambers Heerspink, Dick de Zeeuw
Nature Reviews. Endocrinology|March 27, 2013
Dual RAAS blockade has dual effects on outcomeHiddo J Lambers Heerspink, Dick de Zeeuw
Circulation|March 2, 2011
ONTARGET still OFF-TARGET?Hiddo J Lambers Heerspink, Dick de Zeeuw
The Review of Diabetic Studies : RDS|January 21, 2012
The kidney in type 2 diabetes therapyHiddo J Lambers Heerspink, Dick de Zeeuw
Nature Reviews. Nephrology|January 21, 2015
Clinical trials: New nonabsorbable potassium-exchange resins in hyperkalaemiaSara S Roscioni, Hiddo J Lambers Heerspink
Clinical Journal of the American Society of Nephrology : CJASN|April 19, 2015
Rebuttal of the Con View: Albuminuria Is an Appropriate Therapeutic Target in Patients with CKDHiddo J Lambers Heerspink, Ron T Gansevoort
Clinical Journal of the American Society of Nephrology : CJASN|April 19, 2015
Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro ViewHiddo J Lambers Heerspink, Ron T Gansevoort
Pageof 12